51 results
424B5
OVID
Ovid Therapeutics Inc
15 Nov 23
Prospectus supplement for primary offering
4:11pm
to amending our amended and restated bylaws, the classified board, the size of our board, removal of directors, director liability, vacancies on our board … that the authorized number of directors may be changed only by resolution of our board of directors;
provide that our board of directors are classified
424B5
OVID
Ovid Therapeutics Inc
20 Nov 20
Prospectus supplement for primary offering
4:23pm
of incorporation, including provisions relating to amending our amended and restated bylaws, the classified board, the size of our board, removal … are classified into three classes of directors;
provide that, subject to the rights of any series of preferred stock to elect directors, directors may only
10-Q
mcexo 6s3ol
13 Jun 17
Quarterly report
12:00am
8-K
EX-99.1
pe3jy
2 Oct 23
Dawn of the neurotherapeutics era Dr. Jeremy Levin CEO & Chairman
12:15pm
S-3
hwxoht6ndqc nl
1 Jun 18
Shelf registration
5:14pm
424B5
qjwsbbfif42qxkufa65
21 Feb 19
Prospectus supplement for primary offering
9:22pm
424B5
bgxhw
19 Feb 19
Prospectus supplement for primary offering
4:04pm
424B5
ifzyk37pqucahumub
3 Oct 19
Prospectus supplement for primary offering
4:11pm
424B5
bg8 qk6fz3r8wv
19 Feb 19
Prospectus supplement for primary offering
4:06pm
424B5
8ihf8 pwl
7 Oct 19
Prospectus supplement for primary offering
9:35pm
424B5
jib8w
7 Oct 19
Prospectus supplement for primary offering
9:33pm
424B5
gqgunmj91 9e
3 Oct 19
Prospectus supplement for primary offering
4:07pm
424B5
e3728jrxs40h82
21 Feb 19
Prospectus supplement for primary offering
9:24pm